Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Blagden

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
The Oncologist|February 1, 2013
A study to evaluate the cause of bone demineralization in gynecological cancer survivorsChara Stavraka, Kate Maclaran, Hani Gabra, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 4, 2015
Risk of Ovarian Cancer Relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancerIvana Rizzuto, Chara Stavraka, Jayanta Chatterjee, et al.
Nucleic Acids Research|July 25, 2015
The La-related protein 1-specific domain repurposes HEAT-like repeats to directly bind a 5'TOP sequenceRoni M Lahr, Seshat M Mack, Annie Héroux, et al.
Developmental Biology|July 28, 2009
Drosophila Larp associates with poly(A)-binding protein and is required for male fertility and syncytial embryo developmentSarah P Blagden, Melanie K Gatt, Vincent Archambault, et al.
The Cochrane Database of Systematic Reviews|March 23, 2025
Next-generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancerFarasat Kazmi, Nipun Shrestha, Tik Fung Dave Liu, et al.
Developmental Cell|November 10, 2020
Subcellular mRNA Localization Regulates Ribosome Biogenesis in Migrating CellsMaria Dermit, Martin Dodel, Flora C Y Lee, et al.
RNA Biology|April 15, 2020
LARP1 isoform expression in human cancer cell linesHagen Schwenzer, Mai Abdel Mouti, Pia Neubert, et al.
British Journal of Cancer|November 15, 2007
A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumoursG Attard, J Kitzen, S P Blagden, et al.
Cancer Research|March 16, 2011
Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancerNelofer Syed, Helen M Coley, Jalid Sehouli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2021
A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian CancerFarasat Kazmi, Shibani Nicum, Rene L Roux, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
The Oncologist|February 1, 2013
A study to evaluate the cause of bone demineralization in gynecological cancer survivorsChara Stavraka, Kate Maclaran, Hani Gabra, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 4, 2015
Risk of Ovarian Cancer Relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancerIvana Rizzuto, Chara Stavraka, Jayanta Chatterjee, et al.
Nucleic Acids Research|July 25, 2015
The La-related protein 1-specific domain repurposes HEAT-like repeats to directly bind a 5'TOP sequenceRoni M Lahr, Seshat M Mack, Annie Héroux, et al.
Developmental Biology|July 28, 2009
Drosophila Larp associates with poly(A)-binding protein and is required for male fertility and syncytial embryo developmentSarah P Blagden, Melanie K Gatt, Vincent Archambault, et al.
The Cochrane Database of Systematic Reviews|March 23, 2025
Next-generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancerFarasat Kazmi, Nipun Shrestha, Tik Fung Dave Liu, et al.
Developmental Cell|November 10, 2020
Subcellular mRNA Localization Regulates Ribosome Biogenesis in Migrating CellsMaria Dermit, Martin Dodel, Flora C Y Lee, et al.
RNA Biology|April 15, 2020
LARP1 isoform expression in human cancer cell linesHagen Schwenzer, Mai Abdel Mouti, Pia Neubert, et al.
British Journal of Cancer|November 15, 2007
A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumoursG Attard, J Kitzen, S P Blagden, et al.
Cancer Research|March 16, 2011
Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancerNelofer Syed, Helen M Coley, Jalid Sehouli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2021
A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian CancerFarasat Kazmi, Shibani Nicum, Rene L Roux, et al.
Pageof 6